|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Pfizer |
|---|---|
| Information provided by: | Pfizer |
| ClinicalTrials.gov Identifier: | NCT00611026 |
Purpose
To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder
| Condition | Intervention | Phase |
|---|---|---|
|
Overactive Bladder |
Drug: Tolterodine ER Drug: Placebo Drug: Fesoterodine |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Parallel Assignment, Safety/Efficacy Study |
| Official Title: | 12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder. |
| Estimated Enrollment: | 2160 |
| Study Start Date: | February 2008 |
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| 1: Active Comparator |
Drug: Tolterodine ER
The tolterodine treatment will be 4 mg QD for 12 weeks.
|
| 2: Placebo Comparator |
Drug: Placebo
Placebo treatment will be QD for 12 weeks.
|
| 3: Experimental |
Drug: Fesoterodine
The fesoterodine treatment will start with 4 mg QD for 1 week followed by a forced dose-escalation to 8mg QD for 11 weeks.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
Hide Study Locations| United States, Alabama | |
| Pfizer Investigational Site | |
| Montgomery, Alabama, United States, 36117 | |
| Pfizer Investigational Site | |
| Mobile, Alabama, United States, 36608 | |
| Pfizer Investigational Site | |
| Enterprise, Alabama, United States, 36330 | |
| United States, Arizona | |
| Pfizer Investigational Site | |
| Tucson, Arizona, United States, 85741 | |
| Pfizer Investigational Site | |
| Peoria, Arizona, United States, 85381 | |
| Pfizer Investigational Site | |
| Chandler, Arizona, United States, 85225 | |
| United States, Arkansas | |
| Pfizer Investigational Site | |
| Little Rock, Arkansas, United States, 72205 | |
| United States, California | |
| Pfizer Investigational Site | |
| Vista, California, United States, 92083 | |
| Pfizer Investigational Site | |
| Torrance, California, United States, 90505 | |
| Pfizer Investigational Site | |
| Anaheim, California, United States, 92801 | |
| Pfizer Investigational Site | |
| San Diego, California, United States, 92103 | |
| Pfizer Investigational Site | |
| Westlake Village, California, United States, 91361 | |
| Pfizer Investigational Site | |
| Fresno, California, United States, 93720 | |
| Pfizer Investigational Site | |
| Upland, California, United States, 91786 | |
| Pfizer Investigational Site | |
| Clovis, California, United States, 93611 | |
| Pfizer Investigational Site | |
| Fresno, California, United States, 93710 | |
| United States, Colorado | |
| Pfizer Investigational Site | |
| Englewood, Colorado, United States, 80112 | |
| United States, Connecticut | |
| Pfizer Investigational Site | |
| New London, Connecticut, United States, 06320 | |
| United States, Florida | |
| Pfizer Investigational Site | |
| Loxahatchee, Florida, United States, 33470 | |
| Pfizer Investigational Site | |
| West Palm Beach, Florida, United States, 33409 | |
| Pfizer Investigational Site | |
| Longwood, Florida, United States, 32779 | |
| Pfizer Investigational Site | |
| Lake Worth, Florida, United States, 33461 | |
| Pfizer Investigational Site | |
| Jacksonville, Florida, United States, 32205 | |
| Pfizer Investigational Site | |
| Jacksonville, Florida, United States, 32216 | |
| Pfizer Investigational Site | |
| Tallahassee, Florida, United States, 32308 | |
| Pfizer Investigational Site | |
| Pembroke Pines, Florida, United States, 33024 | |
| Pfizer Investigational Site | |
| Miami, Florida, United States, 33143 | |
| Pfizer Investigational Site | |
| Leesburg, Florida, United States, 34748 | |
| Pfizer Investigational Site | |
| Bonita Spring, Florida, United States, 34134 | |
| Pfizer Investigational Site | |
| Naples, Florida, United States, 34102 | |
| Pfizer Investigational Site | |
| Stuart, Florida, United States, 34996 | |
| Pfizer Investigational Site | |
| Hollywood, Florida, United States, 33021 | |
| Pfizer Investigational Site | |
| Miami, Florida, United States, 33186 | |
| United States, Georgia | |
| Pfizer Investigational Site | |
| Atlanta, Georgia, United States, 30342 | |
| Pfizer Investigational Site | |
| Atlanta, Georgia, United States, 30308 | |
| United States, Idaho | |
| Pfizer Investigational Site | |
| Meridian, Idaho, United States, 83642 | |
| United States, Illinois | |
| Pfizer Investigational Site | |
| Chicago, Illinois, United States, 60654 | |
| Pfizer Investigational Site | |
| Peoria, Illinois, United States, 61614 | |
| United States, Indiana | |
| Pfizer Investigational Site | |
| Avon, Indiana, United States, 46123 | |
| Pfizer Investigational Site | |
| Evansville, Indiana, United States, 47714 | |
| Pfizer Investigational Site | |
| Noblesville, Indiana, United States, 46158 | |
| United States, Kansas | |
| Pfizer Investigational Site | |
| Overland Park, Kansas, United States, 66210 | |
| Pfizer Investigational Site | |
| Overland Park, Kansas, United States, 66215 | |
| United States, Kentucky | |
| Pfizer Investigational Site | |
| Louisville, Kentucky, United States, 40207 | |
| Pfizer Investigational Site | |
| Louisville, Kentucky, United States, 40291 | |
| Pfizer Investigational Site | |
| Lexington, Kentucky, United States, 40504 | |
| Pfizer Investigational Site | |
| Lexington, Kentucky, United States, 40509 | |
| United States, Louisiana | |
| Pfizer Investigational Site | |
| Metairie, Louisiana, United States, 70002 | |
| United States, Maryland | |
| Pfizer Investigational Site | |
| Baltimore, Maryland, United States, 21211 | |
| Pfizer Investigational Site | |
| Bel Air, Maryland, United States, 21014 | |
| United States, Massachusetts | |
| Pfizer Investigational Site | |
| North Dartmouth, Massachusetts, United States, 02747 | |
| United States, Michigan | |
| Pfizer Investigational Site | |
| Ann Arbor, Michigan, United States, 48103 | |
| Pfizer Investigational Site | |
| Royal Oak, Michigan, United States, 48073 | |
| Pfizer Investigational Site | |
| Troy, Michigan, United States, 48098 | |
| United States, Minnesota | |
| Pfizer Investigational Site | |
| Edina, Minnesota, United States, 55435 | |
| Pfizer Investigational Site | |
| Sartell, Minnesota, United States, 56377 | |
| United States, Mississippi | |
| Pfizer Investigational Site | |
| Picayune, Mississippi, United States, 39466 | |
| Pfizer Investigational Site | |
| Olive Branch, Mississippi, United States, 38654 | |
| United States, Missouri | |
| Pfizer Investigational Site | |
| St. Louis, Missouri, United States, 63117 | |
| Pfizer Investigational Site | |
| Kansas City, Missouri, United States, 64114 | |
| United States, Nebraska | |
| Pfizer Investigational Site | |
| Lincoln, Nebraska, United States, 68506 | |
| Pfizer Investigational Site | |
| Lincoln, Nebraska, United States, 68510 | |
| Pfizer Investigational Site | |
| Omaha, Nebraska, United States, 68134 | |
| United States, Nevada | |
| Pfizer Investigational Site | |
| Las Vegas, Nevada, United States, 89148 | |
| United States, New Jersey | |
| Pfizer Investigational Site | |
| Hamilton, New Jersey, United States, 08690 | |
| United States, New York | |
| Pfizer Investigational Site | |
| Williamsville, New York, United States, 14221 | |
| United States, North Carolina | |
| Pfizer Investigational Site | |
| Winston-Salem, North Carolina, United States, 27103 | |
| Pfizer Investigational Site | |
| Cary, North Carolina, United States, 27518 | |
| Pfizer Investigational Site | |
| Raleigh, North Carolina, United States, 27612 | |
| Pfizer Investigational Site | |
| Raleigh, North Carolina, United States, 27609 | |
| United States, Ohio | |
| Pfizer Investigational Site | |
| Cincinnati, Ohio, United States, 45212 | |
| Pfizer Investigational Site | |
| Cincinnati, Ohio, United States, 45249 | |
| United States, Pennsylvania | |
| Pfizer Investigational Site | |
| Bensalem, Pennsylvania, United States, 19020 | |
| Pfizer Investigational Site | |
| Pittsburgh, Pennsylvania, United States, 15243 | |
| Pfizer Investigational Site | |
| Uniontown, Pennsylvania, United States, 15401 | |
| Pfizer Investigational Site | |
| Philadelphia, Pennsylvania, United States, 19114 | |
| United States, Rhode Island | |
| Pfizer Investigational Site | |
| Pawtucket, Rhode Island, United States, 02860 | |
| Pfizer Investigational Site | |
| Cumberland, Rhode Island, United States, 02864 | |
| United States, South Carolina | |
| Pfizer Investigational Site | |
| Summerville, South Carolina, United States, 29485 | |
| Pfizer Investigational Site | |
| Greer, South Carolina, United States, 29651 | |
| Pfizer Investigational Site | |
| Anderson, South Carolina, United States, 29621 | |
| United States, Tennessee | |
| Pfizer Investigational Site | |
| Johnson City, Tennessee, United States, 37601 | |
| Pfizer Investigational Site | |
| New Tazewell, Tennessee, United States, 37825 | |
| Pfizer Investigational Site | |
| Nashville, Tennessee, United States, 37203 | |
| United States, Texas | |
| Pfizer Investigational Site | |
| Plano, Texas, United States, 75024 | |
| Pfizer Investigational Site | |
| Plano, Texas, United States, 75093 | |
| Pfizer Investigational Site | |
| San Antonio, Texas, United States, 78229 | |
| Pfizer Investigational Site | |
| Beaumont, Texas, United States, 77701 | |
| Pfizer Investigational Site | |
| Beaumont, Texas, United States, 77706 | |
| Pfizer Investigational Site | |
| Sugar Land, Texas, United States, 77479 | |
| Pfizer Investigational Site | |
| Bryan, Texas, United States, 77802 | |
| United States, Utah | |
| Pfizer Investigational Site | |
| West Jordan, Utah, United States, 84088 | |
| Pfizer Investigational Site | |
| Midvale, Utah, United States, 84047 | |
| United States, Virginia | |
| Pfizer Investigational Site | |
| Virginia Beach, Virginia, United States, 23455 | |
| Pfizer Investigational Site | |
| Charlottesville, Virginia, United States, 22911 | |
| Pfizer Investigational Site | |
| Richmond, Virginia, United States, 23294 | |
| Pfizer Investigational Site | |
| Arlington, Virginia, United States, 22205 | |
| Pfizer Investigational Site | |
| Weber City, Virginia, United States, 24290 | |
| Pfizer Investigational Site | |
| Virginia Beach, Virginia, United States, 23464 | |
| United States, Washington | |
| Pfizer Investigational Site | |
| Seattle, Washington, United States, 98166 | |
| Pfizer Investigational Site | |
| Spokane, Washington, United States, 99207 | |
| Pfizer Investigational Site | |
| Seattle, Washington, United States, 98104 | |
| Brazil, BA | |
| Pfizer Investigational Site | |
| Salvador, BA, Brazil, 40420-000 | |
| Brazil, GO | |
| Pfizer Investigational Site | |
| Goiania, GO, Brazil, 74175-080 | |
| Brazil, PR | |
| Pfizer Investigational Site | |
| Curitiba, PR, Brazil, 80030-220 | |
| Brazil, RJ | |
| Pfizer Investigational Site | |
| Rio de Janeiro, RJ, Brazil, CEP 20551-030 | |
| Brazil, RS | |
| Pfizer Investigational Site | |
| Porto Alegre, RS, Brazil, 90470-340 | |
| Brazil, SP | |
| Pfizer Investigational Site | |
| Sao Paulo, SP, Brazil, 04025-001 | |
| Bulgaria | |
| Pfizer Investigational Site | |
| Sofia, Bulgaria, 1606 | |
| Pfizer Investigational Site | |
| Veliko Tarnovo, Bulgaria, 5000 | |
| Pfizer Investigational Site | |
| Plovdiv, Bulgaria, 4003 | |
| Pfizer Investigational Site | |
| Pernik, Bulgaria, 2300 | |
| Pfizer Investigational Site | |
| Pleven, Bulgaria, 5800 | |
| Pfizer Investigational Site | |
| Plovdiv, Bulgaria, 4002 | |
| Canada, British Columbia | |
| Pfizer Investigational Site | |
| Surrey, British Columbia, Canada, V3V 1N1 | |
| Canada, Manitoba | |
| Pfizer Investigational Site | |
| Winnipeg, Manitoba, Canada, R3C 0N2 | |
| Canada, Nova Scotia | |
| Pfizer Investigational Site | |
| Halifax, Nova Scotia, Canada, B3H 3A7 | |
| Canada, Ontario | |
| Pfizer Investigational Site | |
| Oshawa, Ontario, Canada, L1H 7K4 | |
| Canada, Quebec | |
| Pfizer Investigational Site | |
| Trois-Rivieres, Quebec, Canada, G9A 3V7 | |
| Pfizer Investigational Site | |
| Chicoutimi, Quebec, Canada, G7H 4A3 | |
| Pfizer Investigational Site | |
| Montreal, Quebec, Canada, H1T 2M4 | |
| Pfizer Investigational Site | |
| Montreal, Quebec, Canada, H2X 1N8 | |
| Pfizer Investigational Site | |
| Montreal, Quebec, Canada, H2X 3J4 | |
| Canada, Saskatchewan | |
| Pfizer Investigational Site | |
| Saskatoon, Saskatchewan, Canada, S7K 1N8 | |
| Colombia | |
| Pfizer Investigational Site | |
| Bogota, Colombia | |
| Colombia, Atlantico | |
| Pfizer Investigational Site | |
| Barranquilla, Atlantico, Colombia, 0 | |
| Costa Rica | |
| Pfizer Investigational Site | |
| Alajuela, Costa Rica | |
| Pfizer Investigational Site | |
| Cartago, Costa Rica | |
| Pfizer Investigational Site | |
| San Jose, Costa Rica | |
| Estonia | |
| Pfizer Investigational Site | |
| Tallinn, Estonia, 10611 | |
| Pfizer Investigational Site | |
| Tartu, Estonia, 51014 | |
| Pfizer Investigational Site | |
| Tallinn, Estonia, 10138 | |
| Germany | |
| Pfizer Investigational Site | |
| Muenchen, Germany, 81925 | |
| Pfizer Investigational Site | |
| Muenchen, Germany, 81241 | |
| Pfizer Investigational Site | |
| Krumbach, Germany, 86381 | |
| Pfizer Investigational Site | |
| Marburg, Germany, 35039 | |
| Pfizer Investigational Site | |
| Muelheim A.d. Ruhr, Germany, 45468 | |
| Pfizer Investigational Site | |
| Leipzig, Germany, 04103 | |
| Pfizer Investigational Site | |
| Hamburg, Germany, 20253 | |
| Pfizer Investigational Site | |
| Berlin, Germany, 10629 | |
| Pfizer Investigational Site | |
| Gruenstadt, Germany, 67269 | |
| Pfizer Investigational Site | |
| Berlin, Germany, 10787 | |
| Greece | |
| Pfizer Investigational Site | |
| Larisa, Greece, 41110 | |
| Pfizer Investigational Site | |
| Athens, Maroussi, Greece, 14126 | |
| Pfizer Investigational Site | |
| Alexandroupolis, Greece, 68100 | |
| Pfizer Investigational Site | |
| Thessaloniki, Greece, 546 35 | |
| Greece, Crete | |
| Pfizer Investigational Site | |
| Heraklion/Voutes, Crete, Greece, 71001 | |
| Hungary | |
| Pfizer Investigational Site | |
| Szentes, Hungary, 6600 | |
| Pfizer Investigational Site | |
| Nyiregyhaza, Hungary, 4400 | |
| Pfizer Investigational Site | |
| Salgotarjan, Hungary, 3100 | |
| Pfizer Investigational Site | |
| Gyor, Hungary, 9023 | |
| Pfizer Investigational Site | |
| Debrecen, Hungary, 4043 | |
| India | |
| Pfizer Investigational Site | |
| New Delhi, India, 110001 | |
| India, Andhra Pradesh | |
| Pfizer Investigational Site | |
| Hyderabad, Andhra Pradesh, India, 500 001 | |
| India, Gujarat | |
| Pfizer Investigational Site | |
| Ahmedabad, Gujarat, India, 380 009 | |
| Pfizer Investigational Site | |
| Nadiad, Gujarat, India, 387 001 | |
| India, Karnataka | |
| Pfizer Investigational Site | |
| Bengaluru, Karnataka, India, 560 010 | |
| India, Maharashtra | |
| Pfizer Investigational Site | |
| Pune, Maharashtra, India, 411 053 | |
| Ireland | |
| Pfizer Investigational Site | |
| Dublin, Ireland, 9 | |
| Ireland, Dublin | |
| Pfizer Investigational Site | |
| Beaumont, Dublin, Ireland, 9 | |
| Korea, Republic of | |
| Pfizer Investigational Site | |
| Suwon, Korea, Republic of, 443-721 | |
| Pfizer Investigational Site | |
| Incheon, Korea, Republic of, 405-760 | |
| Pfizer Investigational Site | |
| Seoul, Korea, Republic of, 134-791 | |
| Pfizer Investigational Site | |
| Daegu, Korea, Republic of, 700-721 | |
| Pfizer Investigational Site | |
| Busan, Korea, Republic of, 602-715 | |
| Korea, Republic of, Chonbuk | |
| Pfizer Investigational Site | |
| Chonju, Chonbuk, Korea, Republic of, 561-712 | |
| Latvia | |
| Pfizer Investigational Site | |
| Riga, Latvia, LV 1002 | |
| Lithuania | |
| Pfizer Investigational Site | |
| Vilnius, Lithuania, 01118 | |
| Pfizer Investigational Site | |
| Klaipeda, Lithuania, 94231 | |
| Pfizer Investigational Site | |
| Kaunas, Lithuania, 50425 | |
| Pfizer Investigational Site | |
| Kaunas, Lithuania, 49476 | |
| Pfizer Investigational Site | |
| Vilnius, Lithuania, 10207 | |
| Malaysia | |
| Pfizer Investigational Site | |
| Kuala Lumpur, Malaysia, 50586 | |
| Pfizer Investigational Site | |
| Kuala Lumpur, Malaysia, 59100 | |
| Poland | |
| Pfizer Investigational Site | |
| Slupsk, Poland, 76-200 | |
| Pfizer Investigational Site | |
| Bialystok, Poland, 15-276 | |
| Pfizer Investigational Site | |
| Lublin, Poland, 20-954 | |
| Pfizer Investigational Site | |
| Bydgoszcz, Poland, 85-094 | |
| Pfizer Investigational Site | |
| Krakow, Poland, 30-017 | |
| Pfizer Investigational Site | |
| Poznan, Poland, 61-251 | |
| Pfizer Investigational Site | |
| Gdynia, Poland, 81-366 | |
| Romania | |
| Pfizer Investigational Site | |
| Arad, Romania, 310175 | |
| Pfizer Investigational Site | |
| Bucuresti, Romania, 041345 | |
| Pfizer Investigational Site | |
| Sibiu, Romania, 550245 | |
| Romania, Sector 5, | |
| Pfizer Investigational Site | |
| Bucuresti, Sector 5,, Romania, 050653 | |
| Russian Federation | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 119991 | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 109388 | |
| Pfizer Investigational Site | |
| Saint-Petersburg, Russian Federation, 197022 | |
| Pfizer Investigational Site | |
| St. Petersburg, Russian Federation, 190013 | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 105425 | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 115516 | |
| Pfizer Investigational Site | |
| Rostov-on-Don, Russian Federation, 344022 | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 117997 | |
| Pfizer Investigational Site | |
| Moscow, Russian Federation, 101000 | |
| Pfizer Investigational Site | |
| Saint-Petersburg, Russian Federation, 196247 | |
| Pfizer Investigational Site | |
| Saint-Petersburg, Russian Federation, 199106 | |
| Singapore | |
| Pfizer Investigational Site | |
| Singapore, Singapore, 229899 | |
| Slovakia | |
| Pfizer Investigational Site | |
| Presov, Slovakia, 080 01 | |
| Pfizer Investigational Site | |
| Nitra, Slovakia, 949 01 | |
| Pfizer Investigational Site | |
| Trencin, Slovakia, 911 01 | |
| Pfizer Investigational Site | |
| Povazska Bystrica, Slovakia, 017 01 | |
| Pfizer Investigational Site | |
| Zvolen, Slovakia, 960 01 | |
| South Africa | |
| Pfizer Investigational Site | |
| Pretoria, South Africa, 0083 | |
| Pfizer Investigational Site | |
| Roodepoort, South Africa, 1715 | |
| South Africa, Cape Town | |
| Pfizer Investigational Site | |
| Claremont, Cape Town, South Africa, 8001 | |
| South Africa, Free State | |
| Pfizer Investigational Site | |
| Bloemfontein, Free State, South Africa, 9301 | |
| South Africa, Gauteng | |
| Pfizer Investigational Site | |
| Vosloorus, Gauteng, South Africa, 1475 | |
| South Africa, Kwa Zulu Natal | |
| Pfizer Investigational Site | |
| Durban, Kwa Zulu Natal, South Africa | |
| Pfizer Investigational Site | |
| Pietermaritzburg, Kwa Zulu Natal, South Africa, 3201 | |
| Pfizer Investigational Site | |
| Durban, Kwa Zulu Natal, South Africa, 4001 | |
| Spain | |
| Pfizer Investigational Site | |
| Valencia, Spain, 46009 | |
| Pfizer Investigational Site | |
| Madrid, Spain, 28040 | |
| Pfizer Investigational Site | |
| Las Palmas de Gran Canaria, Spain, 35010 | |
| Pfizer Investigational Site | |
| Valencia, Spain, 46017 | |
| Spain, CANTABRIA | |
| Pfizer Investigational Site | |
| Santander, CANTABRIA, Spain, 39008 | |
| Spain, Santa Cruz De Tenerife | |
| Pfizer Investigational Site | |
| La Laguna, Santa Cruz De Tenerife, Spain, 38320 | |
| Sweden | |
| Pfizer Investigational Site | |
| Stockholm, Sweden | |
| Pfizer Investigational Site | |
| Karlskoga, Sweden, 691 81 | |
| Pfizer Investigational Site | |
| Skovde, Sweden, 541 85 | |
| Pfizer Investigational Site | |
| Orebro, Sweden, 701 46 | |
| Pfizer Investigational Site | |
| Norrkoping, Sweden, 601 82 | |
| Pfizer Investigational Site | |
| Malmo, Sweden, 211 52 | |
| Ukraine | |
| Pfizer Investigational Site | |
| Dnipropetrovsk, Ukraine, 49005 | |
| Pfizer Investigational Site | |
| Zaporizhzhia, Ukraine, 69000 | |
| Pfizer Investigational Site | |
| Uzhorod, Ukraine, 88000 | |
| Pfizer Investigational Site | |
| Kyiv, Ukraine, 04053 | |
| Pfizer Investigational Site | |
| Chernivtsi, Ukraine, 58002 | |
| Study Director: | Pfizer CT.gov Call Center | Pfizer |
More Information
| Responsible Party: | Pfizer Inc ( Director, Clinical Trial Disclosure Group ) |
| Study ID Numbers: | A0221046 |
| Study First Received: | January 28, 2008 |
| Last Updated: | November 23, 2009 |
| ClinicalTrials.gov Identifier: | NCT00611026 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Treatment of overactive bladder |
|
Urinary Bladder, Overactive Neurotransmitter Agents Cholinergic Antagonists Molecular Mechanisms of Pharmacological Action Urinary Bladder Diseases Physiological Effects of Drugs Cholinergic Agents |
Pharmacologic Actions Muscarinic Antagonists Urological Manifestations Signs and Symptoms Urologic Diseases Tolterodine |